Career history of Charity Scripture
Former positions of Charity Scripture
| Companies | Position | Start | End |
|---|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2018-12-31 | 2024-02-22 |
| ACELYRIN, INC. | Corporate Officer/Principal | - | - |
Training of Charity Scripture
| Hamilton College (New York) | Undergraduate Degree |
| Dartmouth Medical School | Graduate Degree |
| University of North Carolina at Chapel Hill | Doctorate Degree |
Statistics
International
| United States | 5 |
| 2 |
Operational
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ACELYRIN, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
- Stock Market
- Insiders
- Charity Scripture
- Experience
